技术专栏

参考资料
信号通路
FAQ
技术讨论
当前位置： 首页>技术专栏>参考资料
Nuciferine activates intestinal TAS2R46 to attenuate metabolic disorders and hyperlipidemia via hepatic VLDL regulation
发布时间：2025-04-22 文章来源：瑞迪生物 阅读次数：130次
上一篇：Immune cell targeting-mediated cytomimetic drug delivery system for BBB-penetrating and precise therapy of in situ glioma 下一篇：Personalized Immunotherapy in Osteoarthritis: A Clinical Trial of Autologous Dendritic Cell Immunotherapy in Knee Osteo-Arthritis